The Great National Cancer Vaccine Summit

09:00 am
06 Mar, 2024
Leonardo Royal London Tower Bridge

The Great National Cancer Vaccine Summit

09:00 am
06 Mar, 2024
Leonardo Royal London Tower Bridge

The UK is pioneering a unique National Cancer Vaccine Advance. This groundbreaking strategy could transform the outcomes of patients with cancer. It involves placing 10,000 patients through clinical trials by 2030. Doctors will utilise mRNA technology used to make coronavirus vaccines and use the technology to trial in cancer patients. If achieved, it will bring the UK back into the global vaccine main stage. These advances made by our country are potentially of historical level achievement, and the most tangible silver lining of our experiences in recent years.

The Great National Cancer Vaccine Summit will showcase the incredible progress and achievements around the country. We know that the most brilliant people have been working very hard in our best cancer centres, within the most agile organisations to give this advance a chance of success. The conference aims to foster a collaborative environment that encourages the exchange of knowledge, best practices, and innovative approaches to help people affected by cancer.

With attendees from industry, government, public sector, academia, research system and of course healthcare, together we will delve into the intricacies of this incredible national cancer vaccine advance that has captured the public imagination. The Great National Cancer Vaccine Summit seeks to underscore the global implications, paving the way for international collaborations and partnerships aimed at redefining the future of cancer care on a global scale.

Key Challenges:

  • Personalisation of cancer vaccines for individual patients
  • Ensuring of access and speed of new clinical trials
  • Integrating new treatment methodologies seamlessly into existing cancer care pathways

Potential Outcomes:

  • Enhanced quality of life for cancer patients
  • A new model of cancer care that is safer and provides better use of cancer treatment centres.
  • Facilitation of quicker, more comfortable, and personalised care for patients

As we celebrate the first year into this significant leap into the future with cancer vaccines, the NHS extends a heartfelt invitation to all oncology specialists and senior leaders to join us at this pivotal conference.

Embrace the opportunity to be at the forefront of groundbreaking advancements in immunotherapy and contribute to shaping the future of cancer care on a global scale.

Registration is free for all NHS oncology specialists, NHS staff, and public sector senior leaders and teams, so secure your place today and be a part of this momentous event that is set to shape the future of cancer treatment.

The Great National Cancer Vaccine Summit Key Subjects

  • How the UK is aspiring to be a Life Sciences and a mRNA vaccine superpower?
  • Why the government deployed its vaccine taskforce model on cancer vaccines?
  • What have we achieved one year into this national cancer vaccine advance?
  • How has focus of NHS England facilitated innovative cancer trial designs, like the “NHS Cancer Vaccine Launchpad”
  • The patient perspective- do we really want cancer vaccines, and will we wait?
  • Advancements in RNA-based immunotherapies/vaccines and their integration into cancer treatment strategies- the genomics laboratories of the future.
  • Our UK cancer vaccine start-ups with ambitions to transform cancer care.
  • Lessons learnt from leading cancer vaccine forums in ensuring fast trial delivery.
  • Benefits and challenges associated with cancer vaccines. Lessons learnt from our very best cancer centres.
  • The clinical debate- has industry got it right in terms of cancer vaccine trial design and/or cancer trial subtypes.
  • What has our regional centres of excellence in cancer vaccines achieved?
  • The nursing research staff- what was needed and what was it like to give a cancer vaccine?
  • From treating cancer, to preventing infections- how might prophylaxis eradicate infections in cancer patients?
  • The trial leads update- flash metrics and the unstoppable tempo of achievements.
  • The scientific basis of mRNA vaccines in cancer treatment, their mode of action, and the look ahead into the next ten years.
  • How industry is working with healthcare systems to ensure that UK patients can get rapid access to novel trials and drugs.
  • The scientific story- ways the cancer vaccine of tomorrow will be better.
  • The final assessment- are we on course to hit the government ambitions for our national cancer vaccine advance- 10,000 patients by 2030, initiating a global advance, and launching trials across early/late stage cancers and across multiple subtypes

Who will Attend

  • Medical oncologists
  • Clinical oncologist
  • Cancer surgeons
  • Cancer trialists
  • Cancer vaccine researchers
  • Cancer trials Unit
  • Cancer alliances
  • NHS Hospital leaderships
  • Public sector research leadership
  • Government Officials

Your Pass Includes....

  • Multiple live keynote presentations
  • Live examples of both NHS and Commercial best practice
  • Breakfast, Lunch and Refreshments included 
  • Meet the supplier sessions.
  • Networking opportunity
  • Live Q&A sessions with all speakers on the day
  • Drinks receptions (subject to event)
  • CPD accreditation
  • Prize draws

Sponsors & Partners

The Agenda

09:00

Registration and Breakfast

Registration and Breakfast

10:00

Chair Opening Address (Confirmed)

Dr Lennard YW Lee
Associate Professor (University of Oxford), Medical Oncologist (NHS), National Clinical Advisor (Office for Life Sciences, NHSE)
University of Oxford

Chair Opening Address (Confirmed)

10:05

Keynote Presentation - Dame Kate Bingham, Board Member, The Francis Crick Institute (Provisonally Confirmed)

Keynote Presentation - Dame Kate Bingham, Board Member, The Francis Crick Institute (Provisonally Confirmed)

10:25

Keynote Presentation - Peter Johnson, Peter Johnstone, Vice Chair at Moffitt Cancer Center (Invited)

Keynote Presentation - Peter Johnson, Peter Johnstone, Vice Chair at Moffitt Cancer Center (Invited)

10:40

Keynote Presentation - Stefan Symeonides, Senior Clinical Lecturer in Medical Oncology, University of Edinburgh (Provisonally Confirmed)

Keynote Presentation - Stefan Symeonides, Senior Clinical Lecturer in Medical Oncology, University of Edinburgh (Provisonally Confirmed)

10:55

Keynote Presentation - Dr. Heather Shaw, Consultant Medical Oncologist, UCL (Provisonally Confirmed)

Keynote Presentation - Dr. Heather Shaw, Consultant Medical Oncologist, UCL (Provisonally Confirmed)

11:10

Keynote Presentation - Professor Gary Middleton, Institute of Immunology and Immunotherapy, Professor of Medical Oncology (Invited)

Keynote Presentation - Professor Gary Middleton, Institute of Immunology and Immunotherapy, Professor of Medical Oncology (Invited)

11:25

Q&A Panel

Q&A Panel

11:30

Morning Break

Morning Break

12:30

Chair Morning Reflection (Confirmed)

Dr Lennard YW Lee
Associate Professor (University of Oxford), Medical Oncologist (NHS), National Clinical Advisor (Office for Life Sciences, NHSE)
University of Oxford

Chair Morning Reflection (Confirmed)

12:35

Case Study

Case Study

12:55

Case Study

Case Study

13:15

Keynote Presentation - Professor Christian Ottensmeier (Confirmed)

Professor Christian Ottensmeier
Professor of Immuno-Oncology, Molecular & Clinical Cancer Medicine / Consultant Medical Oncologist
University of Liverpool / Clatterbridge Cancer Centre

With decades of experience investigating immune responses, Professor Ottesnmeier will share an overview of the successes and challenges leading us to where we are now in cancer vaccine immunology. As a chief investigator on UK vaccine trials and top recruiter in multiple settings, he will share clinical experiences of cancer vaccine trials and explore the path onwards in the national vaccine advance.

13:35

Case Study

Case Study

13:55

Q&A Panel

Q&A Panel

14:00

Networking & Lunch

Networking & Lunch

15:00

Chair Afternoon Address (Confirmed)

Dr Lennard YW Lee
Associate Professor (University of Oxford), Medical Oncologist (NHS), National Clinical Advisor (Office for Life Sciences, NHSE)
University of Oxford

Chair Afternoon Address (Confirmed)

15:05

Case Study

Case Study

15:25

Keynote Presentation - Professor Mererid Evans, Director of Wales Cancer Research Centre (Invited)

Keynote Presentation - Professor Mererid Evans, Director of Wales Cancer Research Centre (Invited)

15:40

Guest Speaker Session

Guest Speaker Session

Dr Pippa Corrie, Consultant Medical Oncologist, Addenbroke's Hospital (Provisionally Confirmed)

Professor Sarah Danson, Clinical Medicine, School of Medicine and Population Health, School Director of Research, Professor of Medical Oncology (Provisionally Confirmed)

15:55

Panel with Q&A

Panel with Q&A

Louise Medley, Consultant in Medical Oncology at Torbay and South Devon NHS Foundation Trust (Provisionally Confirmed)

Nangi Lo, Consultant Medical Oncologist at South Devon Healthcare NHS Foundation Trust (Provisionally Confirmed)

16:10

Panel with Q&A

Panel with Q&A

Jamie Blundell, Research Group Leader, CRUK Cambridge Centre Early Detection Programme (Invited)

Tim Elliott, Kidani Professor of Immuno-Oncology, Co-Director, Cancer Research UK Oxford Center (Invited)

16:25

Hot Buffet Food, Drinks and Networking

Hot Buffet Food, Drinks and Networking

17:25

End of Day

End of Day

Convenzisvents

Tickets For NHS Senior Managers

We have an invite only option for NHS senior managers for our conference, to see if you qualify for a complimentary place please click the button below.

Apply for NHS Ticket

Book your Place

Free Tickets

To apply for a free ticket please select one of the options below.

Apply for FREE NHS Tickets Here

Apply for FREE Public Sector Tickets Here

Paid Tickets

Ticket
Price
Quantity
Charity, Not for Profit and University (In-Person)
£203.99 excl VAT
Unlimited places
0
Private Sector In-Person
£406.99 excl VAT
Unlimited places
0
abpco 2021
Manchester Bee
CPD Member
Living Wage Member
Good Employment - Sponsor
Good Employment - Member
Armed Forces Covenant
Tech UK
HPMA
IHSCM
FSB
Ban The Box
Faculty of Clinical Informatics
Stockport County
Convenzis Healthcare Event testimonials

What our clients say about us

Working with Convenzis is a stress-free and a rewarding experience, with fantastic engagement from a highly targeted and relevant audience

Zoom

I worked with Convenzis, primarily Dan, for the first time this year, putting together a bespoke online event for IBM. He has always been so responsive and accommodating. The team always remained professional and helpful – despite the many demands from our side! They were very keen for us to maximise on the investment and revisit those attendees who had not committed to follow ups.
It was an absolute pleasure doing business with Convenzis and I know there will be more opportunities next year. Looking forward to it!

IBM

In view of the recent NHS Oncology Conference organised by CONVENZIS which was sponsored by Pascoe Healthcare Ltd, CONVENZIS exhibited professionalism through credible organisation, invitation of delegates/respectable Speakers and general conduct of the entire conference. This has also shown that CONVENZIS is a great partner in business which is fundamental to ROI of partnering Companies even in the wake of the pandemic.

Pascoe Healthcare

“We’ve worked with the Convenzis team for several years and their events are a regular occurrence for us. Not only is the content always extremely topical, but the speakers are always excellent and the support from the team ahead of and during the events is exceptional. The team are incredibly receptive to feedback and always goes above and beyond – a real pleasure to work with!”

eConsult

“It has been a pleasure to work with Matt and Dan for the past few events. Everything has always run smoothly and we’ve always managed to gather a large number of interested parties due to the events they have hosted.

They are also very helpful and timely in their responses, which has made working with them very easy “

Piota